Richard D Connell

Title: Richard D Connell: Innovator in Immunosuppressant Compounds

Introduction

Richard D Connell is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of immunology through his innovative work on immunosuppressant compounds. With a total of 4 patents to his name, Connell has established himself as a key figure in the development of new therapeutic agents.

Latest Patents

Connell's latest patents include groundbreaking research on 2-oxoethyl derivatives as immunosuppressants. This class of compounds is designed to suppress human T-lymphocyte proliferation, which is crucial for managing immune responses. The active compounds contain specific structural features that enhance their efficacy. Another significant patent focuses on aminomethylene derivatives as immunosuppressants, which also aim to suppress human T-lymphocyte proliferation through similar structural characteristics.

Career Highlights

Connell is currently associated with Miles Inc., where he continues to advance his research in immunology. His work has been instrumental in developing new treatments that can improve patient outcomes in various medical conditions requiring immunosuppression.

Collaborations

Connell has collaborated with esteemed colleagues such as David G Osterman and Michael E Katz. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective therapeutic solutions.

Conclusion

Richard D Connell's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in immunosuppressant therapies.